Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity
Arthritis Research & Therapy, 07/08/09
Toussirot E et al. – Spondylarthropathies (SpA) patients exhibit high levels of circulating soluble form of CTLA-4 (sCTLA-4) that may result from an alternative splicing of CTLA-4 transcripts; may influence immune activation and regulation in SpA.
Methods- Main objectives of this study were to:
- Evaluate the circulating levels of sCTLA-4 as a marker of immune dysregulation in SpA
- Study the intracellular CTLA-4 and levels of CTLA-4 transcript expression in peripheral blood lymphocytes (PBL)
- Sera from 165 pts were evaluated for sCTLA-4 measurements
- Results were compared to those from 71 RA pts and 88 healthy subjects
- In 32 pts with SpA, 22 pts with RA and 15 healthy controls, intracellular CTLA-4 expression in:
- CD4+ T cells
- CD8+ T cells
- Activated (HLA-DR+Foxp3-) CD4+ T cells
- CD4+ regulatory (CD25+Foxp3+) T cells and in
- CD3 negative cells
- were analyzed by flow cytometry
- Expression of the full length and spliced form of CTLA-4 transcripts in PBL were analyzed by qRT-PCR
- High levels of sCTLA-4 were found in the SpA group vs RA group and healthy controls
- Soluble CTLA-4 serum levels strongly correlated with clinical index of disease activity BASDAI and CRP levels
- In contrast to RA pts, SpA pts did not exhibit changes in intracellular CTLA-4 expression in the different PBL subsets tested
- Finally, the SpA group showed a preferential expression of the spliced CTLA-4 mRNA in PBL
Today in Spondylarthropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
Erythrocyte sedimentation rate, CRP level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
Arthritis Care and Research , 11/02/09
Agreement between quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis
Journal of Rheumatology, 11/18/09
Insights into the pathogenesis of axial spondyloarthropathy based on gene expression profiles
Arthritis Research & Therapy, 11/10/09
Sponsor
Article Search
Sponsor


See Latest Articles


